Characterization of siamycin I, a human immunodeficiency virus fusion inhibitor - Test2 - elhamkhani - TriplyDB

Characterization of siamycin I, a human immunodeficiency virus fusion inhibitor

Characterization of siamycin I, a human immunodeficiency virus fusion inhibitor

http://www.wikidata.org/entity/Q28379084

about

Precursor-centric genome-mining approach for lasso peptide discovery Mechanisms and modifications of naturally occurring host defense peptides for anti-HIV microbicide development Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature.Inhibition of human immunodeficiency virus type 1 entry by a binding domain of Porphyromonas gingivalis gingipain Mannose-specific plant lectins from the Amaryllidaceae family qualify as efficient microbicides for prevention of human immunodeficiency virus infection.Siamycin attenuates fsr quorum sensing mediated by a gelatinase biosynthesis-activating pheromone in Enterococcus faecalis.

P2860

Q27672155-A6F37465-9238-4DC9-AF5E-9A2938B473AB Q28257799-2FF16D30-D3B4-45D2-867B-8E184963DB0B Q34312732-7985E861-9D52-4AA3-BB1A-F317309F864A Q35023268-36FD7EE1-CD6B-4C05-97BE-F878EECB48B9 Q37568901-F699E591-FB52-43E9-B9BF-7E19AB3A9825 Q41941850-4283E719-AC62-471B-AB4C-4DFD1D9ADD60

P2860

Characterization of siamycin I, a human immunodeficiency virus fusion inhibitor

http://www.wikidata.org/entity/Q28379084

description

1996 nî lūn-bûn

@nan

1996 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1996 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

name

Characterization of siamycin I, a human immunodeficiency virus fusion inhibitor

@ast

Characterization of siamycin I, a human immunodeficiency virus fusion inhibitor

@en

Characterization of siamycin I, a human immunodeficiency virus fusion inhibitor

@nl

type

label

Characterization of siamycin I, a human immunodeficiency virus fusion inhibitor

@ast

Characterization of siamycin I, a human immunodeficiency virus fusion inhibitor

@en

Characterization of siamycin I, a human immunodeficiency virus fusion inhibitor

@nl

prefLabel

Characterization of siamycin I, a human immunodeficiency virus fusion inhibitor

@ast

Characterization of siamycin I, a human immunodeficiency virus fusion inhibitor

@en

Characterization of siamycin I, a human immunodeficiency virus fusion inhibitor

@nl

P1433

Q28379084-7A9E8B48-6A8D-4A70-B968-CB18C9AD8EAF

P1476

Q28379084-F6845B22-A8C3-4CFD-968F-1C631D1B3364

P2093

Q28379084-1793EC8F-57B6-4A89-9086-E50AC60A510A

Q28379084-30F4A7B5-FD20-4777-B78F-785C7BDC03E5

Q28379084-5984FB98-A861-4602-9847-6D9EBF0C9794

Q28379084-5A31025E-8984-4AEA-9022-D2D33144368B

Q28379084-5EA15D62-DCA4-4004-9956-03C1EEFDEDAF

Q28379084-617478A2-6F30-42A0-9142-966A79788991

Q28379084-A0BBA2F2-D1D9-425C-AEDD-A5F82750E047

Q28379084-D9D9DD62-8D91-40B0-9C40-895A3BAF498A

Q28379084-E12B2923-FBF2-4C04-BC59-A6CA31B6F066

Q28379084-F5224CBA-E80E-44FF-ABF8-1D4A75C025DB

P2860

Q28379084-04464CE9-6C41-4EE0-B15E-23C358EE4AE6

Q28379084-0D21134A-3222-4BD7-B2B8-98A08CB2AB8A

Q28379084-0DBC0CCC-3458-4C7F-9BAE-C57425D1B66E

Q28379084-0E87A334-677E-4627-8AA5-FBCA92A1D435

Q28379084-16E24D00-FEE5-4EDD-9D11-6476658995FA

Q28379084-1B20877D-2DF8-46E0-837A-827B4DE5359B

Q28379084-1F5C9B30-F3AE-46B5-9057-5E9941AB0959

Q28379084-241D31E4-F39D-4135-B3E3-C692DA9F0392

Q28379084-27F49BFE-1AA2-4C23-B47A-2AD9040683FB

Q28379084-298E4A58-CD4A-4986-99B4-310DFC2B3BBF

P304

Q28379084-5EC1B1D8-B6C8-4983-81CC-DDA0F4AE6485

P31

Q28379084-A6EA1582-09F1-454A-9477-DBF58E57A772

P356

Q28379084-0560C2B1-96AD-4F7C-AC5F-D0177612B23C

P407

Q28379084-668D79DF-67AD-479B-BC12-188CDF476AED

P433

Q28379084-815C3F39-550E-44C1-B192-620D60A43D5F

P478

Q28379084-ABDBB83A-CBF0-43B2-B4DB-274614812F16

P577

Q28379084-45BF0E6D-E169-4146-99CC-A9EB6F144460

P698

Q28379084-404204C9-D085-48FA-BE97-A2F323B4D67D

P921

Q28379084-1DFA88B7-C0C7-452B-A5BB-D264136D4E58

P932

Q28379084-A23AE805-3CC3-4D23-B731-460A716D2E94

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Characterization of siamycin I, a human immunodeficiency virus fusion inhibitor

@en

P2093

Alam M

http://www.w3.org/2001/XMLSchema#string

Bechtold CM

http://www.w3.org/2001/XMLSchema#string

Colonno RJ

http://www.w3.org/2001/XMLSchema#string

Deminie CA

http://www.w3.org/2001/XMLSchema#string

Lin PF

http://www.w3.org/2001/XMLSchema#string

Patick AK

http://www.w3.org/2001/XMLSchema#string

Riccardi K

http://www.w3.org/2001/XMLSchema#string

Rose RE

http://www.w3.org/2001/XMLSchema#string

Samanta H

http://www.w3.org/2001/XMLSchema#string

White RJ

http://www.w3.org/2001/XMLSchema#string

P2860

Efficient particle formation can occur if the matrix domain of human immunodeficiency virus type 1 Gag is substituted by a myristylation signal

Solution structure of RP 71955, a new 21 amino acid tricyclic peptide active against HIV-1 virus

Anti-human immunodeficiency virus activity of a novel synthetic peptide, T22 ([Tyr-5,12, Lys-7]polyphemusin II): a possible inhibitor of virus-cell fusion

A novel anti-HIV synthetic peptide, T-22 ([Tyr5,12,Lys7]-polyphemusin II)

Oligopeptide inhibitors of HIV-induced syncytium formation

Antiviral properties of aminodiol inhibitors against human immunodeficiency virus and protease

Characterization of a human immunodeficiency virus type 1 variant with reduced sensitivity to an aminodiol protease inhibitor

Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection

Amphotericin B derivative blocks human immunodeficiency virus type 1 entry after CD4 binding: effect on virus-cell fusion but not on cell-cell fusion

Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells

P304

133-138

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.40.1.133

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P577

1996-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8787894

http://www.w3.org/2001/XMLSchema#string

P921

membrane fusion involved in viral entry into host cell

P932

163071

http://www.w3.org/2001/XMLSchema#string